Teradyne (NASDAQ:TER) Price Target Raised to $465.00 at The Goldman Sachs Group

Teradyne (NASDAQ:TER) had its price objective raised by investment analysts at The Goldman Sachs Group from $350.00 to $465.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price indicates a potential upside of 18.41% from the company’s current price.

Several other research analysts also recently commented on TER. Susquehanna lifted their target price on Teradyne from $415.00 to $550.00 and gave the stock a “positive” rating in a report on Tuesday, June 30th. Evercore set a $370.00 price target on Teradyne in a research note on Thursday, April 30th. Citigroup raised their price objective on Teradyne from $325.00 to $400.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. Morgan Stanley set a $387.00 price objective on Teradyne in a research note on Thursday, April 30th. Finally, Bank of America upped their target price on Teradyne from $365.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $390.53.

Teradyne Stock Up 6.4%

Shares of TER stock traded up $23.61 during trading hours on Monday, hitting $392.70. 985,268 shares of the company’s stock traded hands, compared to its average volume of 3,862,015. The stock has a market cap of $61.47 billion, a PE ratio of 72.44, a price-to-earnings-growth ratio of 1.07 and a beta of 1.74. The stock’s 50 day simple moving average is $386.59 and its 200 day simple moving average is $317.34. Teradyne has a 12 month low of $88.60 and a 12 month high of $487.91.

Teradyne (NASDAQ:TER) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.11 by $0.45. The company had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.20 billion. Teradyne had a net margin of 22.55% and a return on equity of 31.79%. Teradyne’s revenue for the quarter was up 87.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.75 earnings per share. As a group, equities research analysts expect that Teradyne will post 7.2 EPS for the current fiscal year.

Insider Buying and Selling

In other Teradyne news, CEO Gregory Stephen Smith sold 8,597 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $338.98, for a total value of $2,914,211.06. Following the completion of the sale, the chief executive officer owned 124,470 shares of the company’s stock, valued at approximately $42,192,840.60. This trade represents a 6.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Ryan Driscoll sold 680 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $377.60, for a total value of $256,768.00. Following the sale, the vice president owned 7,665 shares of the company’s stock, valued at approximately $2,894,304. This represents a 8.15% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 14,941 shares of company stock valued at $5,444,112. 0.19% of the stock is owned by company insiders.

Institutional Trading of Teradyne

Several hedge funds have recently bought and sold shares of the business. State Street Corp lifted its stake in shares of Teradyne by 0.9% in the fourth quarter. State Street Corp now owns 7,078,635 shares of the company’s stock valued at $1,370,141,000 after buying an additional 60,986 shares in the last quarter. Ameriprise Financial Inc. lifted its position in Teradyne by 6.8% in the 3rd quarter. Ameriprise Financial Inc. now owns 5,256,857 shares of the company’s stock valued at $723,600,000 after acquiring an additional 336,757 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in Teradyne by 18.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,203,546 shares of the company’s stock valued at $813,640,000 after acquiring an additional 659,273 shares in the last quarter. Invesco Ltd. boosted its stake in Teradyne by 3.5% during the 3rd quarter. Invesco Ltd. now owns 2,959,330 shares of the company’s stock valued at $407,322,000 after purchasing an additional 99,864 shares during the last quarter. Finally, Alkeon Capital Management LLC boosted its stake in Teradyne by 48.6% during the 3rd quarter. Alkeon Capital Management LLC now owns 2,872,910 shares of the company’s stock valued at $395,427,000 after purchasing an additional 940,000 shares during the last quarter. Institutional investors and hedge funds own 99.77% of the company’s stock.

Teradyne Company Profile

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.